Eritroderma
-
Upload
rajaalfatih -
Category
Documents
-
view
88 -
download
4
Transcript of Eritroderma
![Page 1: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/1.jpg)
04/08/23 1
2009
Departemen Ilmu Kesehatan Kulit dan Kelamin Fakultas Kedokteran
UNSRI/RSMH Palembang2011
M . IZAZI HP
Exfoliative dermatitis
dr. M. Izazi HP SpKK
![Page 2: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/2.jpg)
characterized diffuse erythema & scaling involving >90% total body skin surface
Cause ED unknown, approximately 20% cases idiopathic ED
Exfoliative dermatitis (ED) or Erythroderma
04/08/23 2dr. M. Izazi HP SpKK
![Page 3: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/3.jpg)
Exfoliative dermatitis (ED)
Common underlying etiologies psoriasis, atopic dermatitis, spongiotic dermatoses,drug hypersensitivity reaction, cutaneous T cell lymphoma(CTCL)
Systemic complications fluid & electrolyte imbalance, thermoregulatory disturbance, fever, tachycardi, High-output failure, hypoalbuminemia, peripheral edema
04/08/23 3dr. M. Izazi HP SpKK
![Page 4: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/4.jpg)
Epidemiology
Incidence 0,9-71,0/100000 outpatient Male > female ratio 2,1 : 4,1 Average onset 41 – 61, rare children Many diseases associated ED
exacerbation previously localized disease >1/2
psoriasis identified almost ¼ cases
04/08/23 4dr. M. Izazi HP SpKK
![Page 5: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/5.jpg)
Etiology
Drug Calcium channel blocker Anti-epileptic antibiotics (penicillin family, sulfonamides
vancomycin Allopurinol,gold,lithium Quinidine Cimetidine Dapsone
04/08/23 5dr. M. Izazi HP SpKK
![Page 6: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/6.jpg)
ED atopic dermatitis
ED atopic dermatitis, psoriasis and CTCL Circulating intercellular adhesion molecule 1 (ICAM 1) Vascular cell adhesion molecule1 (VCAM1) E-selectin
04/08/23 6dr. M. Izazi HP SpKK
![Page 7: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/7.jpg)
Possible trigger ED psoriasis
Discontinuation poten topical or oral CS, metotraxate, or biologic treatment (efalizumab)
Medicationlithium,terbinafine,antimalaria Topical irritanTar Infection HIV infections Pregnancy Emotional stress Systemic illness04/08/23 7dr. M. Izazi HP SpKK
![Page 8: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/8.jpg)
Chronic Idiopathic ED
risk progression mycosis fungoides or sezary syndrome
Theorieschronic T-cell stimulation in chronic ED (atopic ED)promote developed CTCL
In elderly patients with chronic or relapsing ED monoclonal CD4+CD7- CD26- lymphocytes monoclonal T-cell dyscrasia of undertermined significance
04/08/23 8dr. M. Izazi HP SpKK
![Page 9: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/9.jpg)
Pathogenesis
Not well understood Theorized staphylococcus aereus
colonization (83% in the nares& 17% skin &nares) or another antigen (shock syndrome toxin-1)
Cytokine profileTh1 cytokine profilebenign ED
Sezary syndrome Th2cytokine IgE
Different mechanism
04/08/23 9dr. M. Izazi HP SpKK
![Page 10: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/10.jpg)
ED in psoriasis
Universal erythem, thickening skin, heavy scaling
Patient had fatigue,malaise, shivering
04/08/23 10dr. M. Izazi HP SpKK
![Page 11: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/11.jpg)
BLEPHARITIS ED atopic dermatitis
Chronicity,edema,lichenification skin induration
Ectropion & epiphora secondary to chronic periorbital involvement
04/08/23 11dr. M. Izazi HP SpKK
![Page 12: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/12.jpg)
ED in pityriasis rubra pilaris
04/08/23 12dr. M. Izazi HP SpKK
![Page 13: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/13.jpg)
SEZARY SYNDROME
04/08/23 13dr. M. Izazi HP SpKK
![Page 14: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/14.jpg)
Related physical finding
Thermoregulator disturbance hyperthermia/ hypothermiamost patients complain of feeling chilly
Tachycardiaincreased blood flow to the skin High-output cardiac failure Peripheral pedal or pretibial edema Generalized lymphadenopathy Hepatomegaly Splenomegaly
04/08/23 14dr. M. Izazi HP SpKK
![Page 15: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/15.jpg)
Non specificAnemia, leucocytosis, lymphocitosis eosinophilia, IgE, ERSabnormal Electrolyte & creatinine
Sezary syndrome circulating cell sezary >20%Quantitative real-time PCR assay molecular diagnosis Sezary syndromePredominance CD4+
Laboratoric finding
04/08/23 15dr. M. Izazi HP SpKK
![Page 16: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/16.jpg)
Complication
Systemic fluid & electrolyte imbalance Thermoregulatory disturbance Fever Hypoalbunemia Peripheral edema susceptibility bacterial colonization Sepsis CTCL & HIV (+) risk staphylococcus sepsis
04/08/23 16dr. M. Izazi HP SpKK
![Page 17: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/17.jpg)
Treatment
fluid & electrolyte Replacement ED caused drug discontinous Enviroment warm & humid Preventing hypothermia Gentle local skin care Bland emollient
04/08/23 17dr. M. Izazi HP SpKK
![Page 18: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/18.jpg)
Treatment
04/08/23 18dr. M. Izazi HP SpKK
![Page 19: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/19.jpg)
Topical treatment
Started CS low potency CS high potency, immunomodulator
(tacrolimus) avoided Topical irritants (anthralin&tar) avoided
Systemic absorption
04/08/23 19dr. M. Izazi HP SpKK
![Page 20: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/20.jpg)
Treatment systemic
Psoriasis EDSystemic CS avoided Psoriasis ED reponsive MTX,
cyclosporine,acitretin, mycophenolate mofetil, th/ biologic
04/08/23 20dr. M. Izazi HP SpKK
![Page 21: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/21.jpg)
Treatment symptomatic
Sedating antihistaminpruritusDiuretica & leg elevation leg edema refractorySystemic antibiotic localized & systemic secondary infection Without evidence secondary infection as
bacterial colonization
04/08/23 21dr. M. Izazi HP SpKK
![Page 22: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/22.jpg)
CBC=complete blood
cell
CXR=chest X-ray
PCP=primary care physician
Approach ED
04/08/23 22dr. M. Izazi HP SpKK
![Page 23: Eritroderma](https://reader033.fdocuments.in/reader033/viewer/2022061113/545cb84bb1af9f3b3c8b4a31/html5/thumbnails/23.jpg)
04/08/23 23dr. M. Izazi HP SpKK